$CRDL Update: Our recent topline ARCHER data demon
Post# of 110708
As CEO David Elsley explains, this finding not only advances our myocarditis program but also highlights the broader potential in heart failure — a condition that is an order of magnitude greater in prevalence and medical burden, representing one of modern medicine’s most pressing unmet needs.
$CRDL | #CardiolRx #Biotech #HeartHealth
https://x.com/CardiolRx/status/1983197260251799607
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/